









Markets
/
Stocks
/
nasdaq-aiff
/

Firefly Neuroscience Inc

AIFF

2.180USD

-0.840-27.81%

Close 03/27, 16:00（ET）Quotes delayed by 15 min

813.63KMarket Cap

LossP/E TTM



Firefly Neuroscience Inc

2.180

-0.840-27.81%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Firefly Neuroscience Inc

Currency: USD Updated: 2026-03-27

Key Insights

Firefly Neuroscience Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 232 out of 480 in the Software & IT Services industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Firefly Neuroscience Inc's Score

Industry at a Glance

Industry Ranking

232 / 480

Overall Ranking

397 / 4542

Industry

Software & IT Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Firefly Neuroscience Inc Highlights

StrengthsRisks

Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company developing neuroscientific solutions to improve brain health outcomes for patients with mental illnesses and neurological disorders. The Company has developed its FDA-510(k) cleared Brain Network Analytics software platform (the BNA Platform) and is focused on advancing diagnostic and treatment approaches for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. The Company's Brain Network Analytics is a neurophysiological assessment tool that uses artificial intelligence and machine learning to analyze electroencephalogram (EEG) data recorded during rest and cognitive activity. The BNA Platform, in conjunction with an EEG system, provides clinicians with comprehensive insights into brain function (cognition).

Growing

The company is in a growing phase, with the latest annual income totaling USD 108.00K.

Fairly Valued

The company’s latest PE is -0.96, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 953.14K shares, decreasing 45.63% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 503.07K shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.22.

Analyst Rating

Based on 0 analysts

Current Rating

Target Price

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-27

The current financial score of Firefly Neuroscience Inc is 7.11, ranking 240 out of 480 in the Software & IT Services industry. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 388.00K, representing a year-over-year increase of 1075.76%, while its net profit experienced a year-over-year increase of 38.47%.

Score

Industry at a Glance

Previous score

7.11

Change



Financials

9.33

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.28

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

2.98

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

8.67

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.29

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Firefly Neuroscience Inc's Company Valuation

Currency: USD Updated: 2026-03-27

The current valuation score of Firefly Neuroscience Inc is 8.18, ranking 114 out of 480 in the Software & IT Services industry. Its current P/E ratio is -0.96, which is -78.20% below the recent high of -0.21 and -903.96% above the recent low of -9.68.

Score

Industry at a Glance

Previous score

8.18

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 232/480

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-27

No earnings forecast score is currently available for Firefly Neuroscience Inc. The Software & IT Services industry's average is 7.60.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-27

The current price momentum score of Firefly Neuroscience Inc is 6.03, ranking 371 out of 480 in the Software & IT Services industry. Currently, the stock price is trading between the resistance level at 3.33 and the support level at 0.86, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.44

Change

-0.41

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(3)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

0.031

Buy

RSI(14)

55.508

Neutral

STOCH(KDJ)(9,3,3)

47.616

Neutral

ATR(14)

0.592

High Vlolatility

CCI(14)

57.939

Neutral

Williams %R

59.874

Sell

TRIX(12,20)

3.591

Buy

StochRSI(14)

22.016

Sell

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

2.116

Buy

MA10

2.110

Buy

MA20

1.855

Buy

MA50

1.240

Buy

MA100

1.334

Buy

MA200

2.052

Buy

Institutional Confidence

Currency: USD Updated: 2026-03-27

The current institutional shareholding score of Firefly Neuroscience Inc is 3.00, ranking 284 out of 480 in the Software & IT Services industry. The latest institutional shareholding proportion is 11.24%, representing a quarter-over-quarter increase of 108.87%. The largest institutional shareholder is The Vanguard, holding a total of 503.07K shares, representing 3.20% of shares outstanding, with 264.83% increase in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Johnson (David Ian)

1.12M

+100.00%

Windsor Private Capital LP

752.72K

-31.74%

The Vanguard Group, Inc.

Star Investors

503.07K

+393.27%

RJL 18 Capital Canada LP

499.37K

Lipschitz (Gregory)

431.20K

+2.62%

Roxy Capital Corp.

424.69K

-38.46%

Finn (Christopher)

349.22K

-19.76%

Geode Capital Management, L.L.C.

113.32K

-6.04%

Menawat (Arun Swarup Ph.D.)

99.41K

BlackRock Institutional Trust Company, N.A.

76.12K

+427.30%

Risk Assessment

Currency: USD Updated: 2026-03-27

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Software & IT Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Firefly Neuroscience Inc is 2.03, ranking 396 out of 480 in the Software & IT Services industry. The company's beta value is 0.22. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.